Replies to post #23030 on Revive Therapeutics Ltd (RVVTF)

[ragstorum]

Revive will capture market share with bucillamine pill, my bet also. Merck's comparable play here, the deal w Ridgeback last year.

https://www.merck.com/news/merck-and-ridgeback-bio-announce-closing-of-collaboration-and-licensing-transaction/